BDX - Hot Stocks: AXDX surges nearly 25% EMBC gains on earnings LI slides on mixed earnings HALO also falls

Markets look to start trading on its back foot but shares of Accelerate Diagnostics, Inc. ( NASDAQ: AXDX ) have exploded nearly 25% after entering an agreement with Becton, Dickinson and Company ( BDX ). Also trading in the green are shares of Embecta Corp. ( NASDAQ: EMBC ) as it topped earnings estimates.

Popular EV maker Li Auto Inc. ( NASDAQ: LI ) has declined in the wake of concerns swirling around growth in China and a mixed earnings report. Halozyme Therapeutics ( NASDAQ: HALO ) has dipped lower as well after proposing convertible senior notes.

Gainers

Accelerate Diagnostics, Inc. ( AXDX ) surged 23.2% after Becton, Dickinson and Company ( BDX ) +0.1% signed an agreement to offer AXDX’s rapid testing solution for antibiotic resistance and susceptibility.

Embecta Corp. ( EMBC ) moved up 1.3% in early market trading as the Delaware based firm beat its Q3 GAAP EPS and revenue estimates . EMBC delivered Q3 GAAP EPS of $1.07 which outdid analyst estimates by $0.20. The stock also beat its revenue target by $14.24M, as it reported revenue of $291.1M.

Decliners

The Chinese electric vehicle maker Li Auto Inc. ( LI ) has fallen 5.8% after the stock surpassed Q2 Non-GAAP EPS but missed on revenue . LI reported Q2 Non-GAAP EPS of -$0.02 which topped forecasts by $0.02 while also posting revenue of $1.3B, which missed by $110M.

Halozyme Therapeutics ( HALO ) dipped 2.6% on Monday’s premarket trading session as the biotech firm announced a proposed offering of $500M of convertible senior notes due 2028 . Moreover, the notes are to be offered and sold to "qualified institutional buyers."

To gain further insight and information on the top and bottom performing stocks for the trading session, head over to Seeking Alpha's On The Move section .

For further details see: